Have Your Oncology Trials Got Their Running Shoes?
Oncology is the largest investment area for the pharmaceutical industry, as a result there is a great deal of competition between key players and emphasis on speeding time to market. Benedikte Thunes Akre, Scientific Advisor - Oncology at Bristol Myers-Squibb, spoke to Andrea Charles from Pharma IQ, about the factors critical to the success of clinical development programs and how to overcome the key challenges in optimal clinical development. Akre also shares her...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.